These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15847833)

  • 1. Prednisone for Duchenne muscular dystrophy.
    Dubowitz V
    Lancet Neurol; 2005 May; 4(5):264. PubMed ID: 15847833
    [No Abstract]   [Full Text] [Related]  

  • 2. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
    Moxley RT; Ashwal S; Pandya S; Connolly A; Florence J; Mathews K; Baumbach L; McDonald C; Sussman M; Wade C; ;
    Neurology; 2005 Jan; 64(1):13-20. PubMed ID: 15642897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekend high-dosage prednisone: a new option for treatment of Duchenne muscular dystrophy.
    Moxley RT; Pandya S
    Neurology; 2011 Aug; 77(5):416-7. PubMed ID: 21753162
    [No Abstract]   [Full Text] [Related]  

  • 4. Normal height and weight in a series of ambulant Duchenne muscular dystrophy patients using the 10 day on/10 day off prednisone regimen.
    ten Dam K; de Groot IJ; Noordam C; van Alfen N; Hendriks JC; Sie LT
    Neuromuscul Disord; 2012 Jun; 22(6):500-4. PubMed ID: 22390890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroids in Duchenne muscular dystrophy: a reappraisal.
    Wong BL; Christopher C
    J Child Neurol; 2002 Mar; 17(3):183-90. PubMed ID: 12026233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early prednisone treatment in Duchenne muscular dystrophy.
    Merlini L; Cicognani A; Malaspina E; Gennari M; Gnudi S; Talim B; Franzoni E
    Muscle Nerve; 2003 Feb; 27(2):222-7. PubMed ID: 12548530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guideline on the use of corticosteroids in Duchenne muscular dystrophy from paediatric neurologists, neurologists and rehabilitation physicians].
    de Groot IJ
    Ned Tijdschr Geneeskd; 2006 Mar; 150(12):684-5. PubMed ID: 16613254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy.
    Connolly AM; Schierbecker J; Renna R; Florence J
    Neuromuscul Disord; 2002 Dec; 12(10):917-25. PubMed ID: 12467746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel treatment regimen for Duchenne muscular dystrophy.
    Li M; Cai Y; Zhong M; Zou L; Gong C
    Neuroreport; 2013 Nov; 24(16):924-7. PubMed ID: 24045777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing standardized corticosteroid treatment for Duchenne muscular dystrophy.
    Guglieri M; Bushby K; McDermott MP; Hart KA; Tawil R; Martens WB; Herr BE; McColl E; Wilkinson J; Kirschner J; King WM; Eagle M; Brown MW; Willis T; Hirtz D; Shieh PB; Straub V; Childs AM; Ciafaloni E; Butterfield RJ; Horrocks I; Spinty S; Flanigan KM; Kuntz NL; Baranello G; Roper H; Morrison L; Mah JK; Manzur AY; McDonald CM; Schara U; von der Hagen M; Barohn RJ; Campbell C; Darras BT; Finkel RS; Vita G; Hughes I; Mongini T; Pegoraro E; Wicklund M; Wilichowski E; Bryan Burnette W; Howard JF; McMillan HJ; Thangarajh M; Griggs RC
    Contemp Clin Trials; 2017 Jul; 58():34-39. PubMed ID: 28450193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management.
    Moxley RT; Pandya S; Ciafaloni E; Fox DJ; Campbell K
    J Child Neurol; 2010 Sep; 25(9):1116-29. PubMed ID: 20581335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy.
    Escolar DM; Hache LP; Clemens PR; Cnaan A; McDonald CM; Viswanathan V; Kornberg AJ; Bertorini TE; Nevo Y; Lotze T; Pestronk A; Ryan MM; Monasterio E; Day JW; Zimmerman A; Arrieta A; Henricson E; Mayhew J; Florence J; Hu F; Connolly AM
    Neurology; 2011 Aug; 77(5):444-52. PubMed ID: 21753160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of bisphosphonates on survival for patients with Duchenne muscular dystrophy.
    Gordon KE; Dooley JM; Sheppard KM; MacSween J; Esser MJ
    Pediatrics; 2011 Feb; 127(2):e353-8. PubMed ID: 21242224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent prednisone therapy in Duchenne muscular dystrophy: a randomized controlled trial.
    Beenakker EA; Fock JM; Van Tol MJ; Maurits NM; Koopman HM; Brouwer OF; Van der Hoeven JH
    Arch Neurol; 2005 Jan; 62(1):128-32. PubMed ID: 15642859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New treatment alternatives for Duchenne and Becker muscular dystrophy.
    Restrepo S
    Neurology; 2004 Mar; 62(6):E10. PubMed ID: 15037729
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial.
    Kirschner J; Schessl J; Schara U; Reitter B; Stettner GM; Hobbiebrunken E; Wilichowski E; Bernert G; Weiss S; Stehling F; Wiegand G; Müller-Felber W; Thiele S; Grieben U; von der Hagen M; Lütschg J; Schmoor C; Ihorst G; Korinthenberg R
    Lancet Neurol; 2010 Nov; 9(11):1053-9. PubMed ID: 20801085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [To disseminate standard cares of muscular dystrophy; development of the Japanese clinical guideline for Duchenne muscular dystrophy].
    Matsumura T
    No To Hattatsu; 2014 Mar; 46(2):98-102. PubMed ID: 24738184
    [No Abstract]   [Full Text] [Related]  

  • 18. Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Gloss D; Moxley RT; Ashwal S; Oskoui M
    Neurology; 2016 Feb; 86(5):465-72. PubMed ID: 26833937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prednisone in Duchenne muscular dystrophy.
    Drachman DB; Toyka KV; Myer E
    Lancet; 1974 Dec; 2(7894):1409-12. PubMed ID: 4140328
    [No Abstract]   [Full Text] [Related]  

  • 20. Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy.
    Finsterer J; Stöllberger C
    Neuromuscul Disord; 2009 Jan; 19(1):74; author reply 75. PubMed ID: 19070488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.